TY - JOUR
T1 - Role of GABAA receptors in the ethanol-mediated inhibition of extracellular signal-regulated kinase
AU - Kalluri, Haviryaji S.G.
AU - Ticku, Maharaj K.
N1 - Funding Information:
We thank Ms. Elena Wright for her technical help. This research was supported by the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism Grants AA 12297 and AA 10552.
PY - 2002/9/6
Y1 - 2002/9/6
N2 - In the present study, we demonstrate the involvement of GABAA receptors in the ethanol-mediated modulation of extracellular signal-regulated kinases (ERK). Intraperitoneal (i.p.) administration of ethanol (3.5 g), flurazepam (75 mg) or (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cycloheptane-5,10-iminemaleate (MK-801) (0.4 mg/kg body weight) decreased, while picrotoxin (10 mg/kg body weight) increased, the phosphorylation of ERK following 10 min of their injection. However, the picrotoxin-induced phosphorylation of ERK was inhibited by ethanol, but was not affected by MK-801. These results indicate that ethanol's inhibitory effect on ERK phosphorylation may involve the modulation of GABAA receptor function.
AB - In the present study, we demonstrate the involvement of GABAA receptors in the ethanol-mediated modulation of extracellular signal-regulated kinases (ERK). Intraperitoneal (i.p.) administration of ethanol (3.5 g), flurazepam (75 mg) or (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cycloheptane-5,10-iminemaleate (MK-801) (0.4 mg/kg body weight) decreased, while picrotoxin (10 mg/kg body weight) increased, the phosphorylation of ERK following 10 min of their injection. However, the picrotoxin-induced phosphorylation of ERK was inhibited by ethanol, but was not affected by MK-801. These results indicate that ethanol's inhibitory effect on ERK phosphorylation may involve the modulation of GABAA receptor function.
KW - Ethanol
KW - GABA (γ-amino butyric acid)
KW - MAP (mitogen-activated protein) kinase
UR - http://www.scopus.com/inward/record.url?scp=0037031563&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037031563&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(02)02100-3
DO - 10.1016/S0014-2999(02)02100-3
M3 - Article
C2 - 12223228
AN - SCOPUS:0037031563
VL - 451
SP - 51
EP - 54
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
SN - 0014-2999
IS - 1
ER -